Home » Biotech Start-Ups Covet Tax Credit
Biotech Start-Ups Covet Tax Credit
Angel investors and wealthy individuals promised to invest a little more than $1 million in BioMarker Strategies, a young Baltimore biotech working on medical devices and diagnostics for cancer patients. So Scott Allocco, president of BioMarker, invested 11.5 hours on a sidewalk to snag them thousands of dollars in tax credits.
Washingtonpost.com
Washingtonpost.com
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May